Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
Medical Device Network on MSN
Sophia Genetics and Element partner to advance precision medicine research
The companies’ aim to unite their respective technologies to create an end-to-end workflow for precision medicine research in lab settings.
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...
Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced presentations demonstrating the clinical impact of using its flagship metagenomic ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
In the largest study of its kind, the diagnostic yield of mNGS was greater than conventional test methods mNGS alone identified 34% more pathogens than all direct-detection methods combined 72% of ...
The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...
Antibiotic resistance is quietly spreading worldwide. According to the World Health Organization's (WHO) latest Global ...
IDT and Beckman Coulter Life Sciences' collaboration marks a significant step forward in enabling labs to streamline oncology research workflows with enhanced precision, scalability, and ...
Whether you’re interested in why a living system works as it does or the reasons it goes awry, proteins are a critical part of the molecular picture. The proteins circulating in a person’s plasma can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback